C · Law–case relations
Part 1 lists the elements of the law. Part 2 lists each case; its numbered items use the same numbers as the elements, with the holding and the quoted passage it rests on. Quotations are verbatim; labels are derived annotations, not the source of truth. Muted blocks are not counted as merits applications.
1 · Elements of 15 U.S.C. § 78j
- Statutory commerce, mails, or exchange facility AND
by the use of any means or instrumentality of interstate commerce or of the mails, or of any facility of any national securities exchange - Section 78j(b) rulemaking hook AND
in contravention of such rules and regulations as the Commission may prescribe - Materially false statement or misleading half-truth AND
any manipulative or deceptive device or contrivance - Importance to a reasonable investor AND
any manipulative or deceptive device or contrivance - Intent to deceive, manipulate, or defraud AND
any manipulative or deceptive device or contrivance - Connection with a covered securities or swap transaction OR
in connection with the purchase or sale of any security registered on a national securities exchange or any security not so registered - Private plaintiff's purchaser or seller status AND
in connection with the purchase or sale - Private investor transaction causation AND
any manipulative or deceptive device or contrivance - Actual economic loss in private damages action AND
any manipulative or deceptive device or contrivance - Causal connection between fraud and economic loss AND
any manipulative or deceptive device or contrivance - Fraudulent scheme or deceptive course of business AND
any manipulative or deceptive device or contrivance - Additional criminal mental-state requirement AND
any manipulative or deceptive device or contrivance
2 · Cases (10)
Case identity unavailable — citation unavailable · United States Court of Appeals for the Eleventh Circuit · 2004 (15usc78j: author: unavailable · not independently reviewed)
- Importance to a reasonable investor✓ satisfied · proved
fact · supports Alan Box, EZ’s CEO, and Ginsburg discussed a specific share price, and Ginsburg knew both that Evergreen was interested in acquiring EZ and that EZ was talking to other companies.
fact · supports As for the nonpublic nature of the evidence, the jury heard testimony from Ron Peale, EZ’s CFO, that the talks were confidential.
rule The materiality of an uncertain prospective event “depend[s] at any given time upon a balancing of both the indicated probability that the event will occur and the anticipated magnitude of the event in light of the totality of the company activity.”
held The insider information in this case meets the materiality standard.
✓ satisfied · provedfact · supports As to Katz, Ginsburg was clearly privy to information gleaned under a confidentiality agreement.
fact · supports The jury had before it sufficient evidence to conclude that Ginsburg’s June 16 meeting with Olds indicated to Ginsburg that a deal had to happen fast.
held The jury could reasonably infer that the information was material and nonpublic.
- Intent to deceive, manipulate, or defraud✓ satisfied · proved
fact · supports Ginsburg was chairman and CEO of Evergreen Media Corporation, which owned and operated a number of radio stations. In 1996 Evergreen became interested in acquiring EZ, a corporation that owned radio stations. Ginsburg met with EZ’s CEO Alan Box on Friday, July 12, 1996, and Box told him EZ was considering several “strategic alternatives.” Before the meeting no decision had been made to sell the company. On Sunday evening, July 14, Ginsburg called Mark at 10:02 p.m., and they spoke for 26 minutes. The next day, Monday, July 15, Mark bought 3800 shares of EZ stock. Mark spoke with Jordan in person and on the telephone over the next few days, and they admit they discussed the purchase of EZ stock.
fact · supports On July 24, EZ’s investment banker faxed a letter to Ginsburg stating that EZ bids were due by July 26. At 7:40 a.m. July 25, a call was placed from Ginsburg’s cell phone to his parents’ home. Later that day Mark purchased 3200 shares of EZ stock for Mark and his wife’s joint account. On July 26, Mark purchased 4300 shares of EZ stock for the same joint account and 7500 shares for a trust account for his son. Also on July 26, Ginsburg, on Evergreen’s behalf, submitted a written offer to acquire EZ for cash and stock. On Sunday, July 28, a ten minute call was placed from Ginsburg’s home to Mark’s home. On Monday, July 29, Jordan bought 5000 shares of EZ stock, and an hour later Mark bought 30,000 shares.
fact · supports That same evening, June 16, a call was placed from a cell phone registered to Ginsburg to a phone registered to Mark. The next day, June 17, Mark bought 150,-000 shares of Katz. On July 14, Evergreen/Chancellor announced it would acquire Katz through a tender offer for Katz stock at $11 a share. On July 16 or 17, 1997, Mark sold 132,500 shares of Katz and tendered the rest, resulting in a total profit of $729,000.
fact · cuts-against Ginsburg offered evidence of public information about the companies as motivation for Mark’s trading, argued that the trades were consistent with prior trading history, and put forward innocent explanations for the calls.
rule The SEC must prove violations of § 10(b) and § 14(e), and their supplementary Rules, by a preponderance of the evidence, and may use direct or circumstantial evidence to do so.
held The call/trade pattern occurrences coupled with the jury’s right to disbelieve the innocent explanations of the calls and trades are enough to support the verdict.
Not addressed: elements 1, 2, 3, 6, 7, 8, 9, 10, 11, 12
Case identity unavailable — citation unavailable · United States Court of Appeals for the Fourth Circuit · 2019 (15usc78j: author: unavailable · not independently reviewed)
- Materially false statement or misleading half-truth✓ satisfied · pleaded
fact · supports (1) On April 25, 2011, Rodham claimed that EB-5 funds accounted for only 7.8% of GreenTech's capital during an event in Beijing, China.
fact · supports (1) On November 11, 2011, McAuliffe told a CNBC interviewer that GreenTech "ha[d] only sold 11,000 cars, but it's still a new business for us." J.A. 154.
fact · supports The complaint alleges that each of those statements was false when made because GreenTech (1) had not sold 11,000 cars; (2) did not have a contract with Denmark; (3) had not mass-produced any electric vehicles; and (4) had fewer than one hundred employees.
held The problem for defendants, however, is that their alleged misstatements go beyond mere projections or puffery.
held Plaintiffs' allegation thus counts as an assertion of fact under the case law in this circuit.
- Private investor transaction causation✗ not satisfied · pleaded
fact · supports We accept as true the following facts, which come from plaintiffs' amended complaint. Plaintiffs-Appellants are a group of twenty-seven Chinese citizens who invested $ 500,000 each in a partnership that loaned their money to GreenTech Automotive. GreenTech, founded in 2008, was a Mississippi corporation that wanted to enter the hybrid and electric vehicle markets. Initially, GreenTech planned to produce the "MyCar," a vehicle that would travel at low speeds and thus be subject to lower levels of regulatory scrutiny.
fact · cuts-against But there are no specific allegations that any individual plaintiff encountered any of those alleged misstatements in promotional materials or on Greentech's website.
rule Federal law similarly requires that an investor "justifiably relied" on particular misstatements in an action under Rule 10b-5.
held Plaintiffs' complaint fails to adequately plead justifiable reliance, instead relying only on general and conclusory allegations.
✗ not satisfied · pleaded Not counted: applied/alternativefact · cuts-against But plaintiffs make clear in their complaint that they signed the subscription documents "without reviewing any version."
fact · cuts-against There is no allegation in the complaint that they made any effort to translate the documents into their native language, or even asked any English-speaking attorney or investment advisor to review the documents for them.
held It was unjustifiable to make such an investment in reliance on stray media statements without so much as translating or even reviewing the subscription documents before signing them.
Not addressed: elements 1, 2, 4, 5, 6, 7, 9, 10, 11, 12
Case identity unavailable — citation unavailable · United States Court of Appeals for the First Circuit · 2019 (15usc78j: author: unavailable · not independently reviewed)
- Intent to deceive, manipulate, or defraud✗ not satisfied · pleaded
fact · cuts-against The complaint alleges that Sandrock made this statement before Biogen's October announcement of the PML-related death, and the plaintiffs do not contend that any of the individual defendants knew about that death before Sandrock made this statement. The plaintiffs nevertheless contend that the District Court erred in concluding that the complaint failed adequately to allege that Sandrock made the statement with the "intentional or willful" design to deceive investors.
fact · supports To make this case, the plaintiffs point out that, in August and September of 2014, Dr. Ben Thrower, the medical director at the Shepherd Center in Atlanta, notified Keith Ferguson, the company's senior sales director, and Eric Hall, the medical science liaison for Biogen, that his research showed that patients who were taking Tecfidera had a higher risk of developing low lymphocyte counts than Biogen had originally disclosed. The complaint further alleges that, for this reason, Dr. Thrower chose to discontinue Tecfidera prescriptions for approximately 200 of his patients and to stop issuing new prescriptions for the drug. The complaint also alleges that he told Ferguson and Hall about this development.
fact · cuts-against By April of 2015, according to the complaint, Biogen had already disclosed the PML death and updated the drug's label to account for the increased understanding of its risk.
rule "For an inference of scienter to be strong, 'a reasonable person would [have to] deem [it] cogent and at least as compelling as any opposing inference one could draw from the facts alleged.' "
held And thus, the allegations regarding Sandrock fail to establish a "strong inference" of scienter as to even him, let alone as to any individual defendant.
✗ not satisfied · pleadedfact · supports We first address the January 29, 2015 statement by Kingsley that "Tecfidera [was] on track to become the most prescribed therapy for MS worldwide." The plaintiffs argue that this statement was misleading and creates the "strong inference" of scienter on Kingsley's part, because at the time of the statement, Kingsley knew about both the PML death and about Tecfidera's declining sales and discontinuation rates.
fact · cuts-against At the time that Kingsley made the statement, however, Biogen had already disclosed to the public the news of the PML death, had already changed the drug's label, had already publicized that it expected the drug's growth rate to "slow," and had already disclosed that the drug's discontinuation rates were higher than expected.
fact · cuts-against Yet, the complaint alleges no facts that are illuminating in that regard.
held But, we find no basis for concluding that any of these statements permit us to infer the necessary intent to deceive that could suffice to create the "strong inference" of scienter that the PSLRA requires.
Not addressed: elements 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12
Case identity unavailable — citation unavailable · United States Court of Appeals for the Second Circuit · 2019 (15usc78j: author: unavailable · not independently reviewed)
- Fraudulent scheme or deceptive course of business○ not reached · basis not recorded Not counted: rule-announced/procedural
fact · supports The next morning, on January 28, Afriyie accessed the ADT and Apollo research folders on MSD's shared drive. After doing so, he purchased his first ADT call option. That afternoon, MSD added ADT to its list of "restricted" securities, and Afriyie received an email to this effect. Taken together, the restriction emails Afriyie received informed him that Apollo was planning to acquire ADT. The next day, Afriyie purchased an additional 35 ADT call options. On February 2, although he was not assigned to work on the ADT project, Afriyie accessed documents specific to the Apollo-ADT deal stored on MSD's shared drive. He subsequently purchased over 2,000 additional ADT call options over the course of the ensuing two weeks.
fact · supports Afriyie does not dispute that on his first day of employment with MSD, he signed a confidentiality agreement.
rule Under Chestman , "a person violates [ 17 C.F.R. § 240.10b-5 ] when he misappropriates material nonpublic information in breach of a fiduciary duty or similar relationship of trust and confidence and uses that information in a securities transaction."
held Accordingly, any error in the district court's instruction did not result in prejudice; viewing the charge actually given as a whole, see United States v. Feliciano , 223 F.3d 102, 116 (2d Cir. 2000), the outcome of the trial would have been the same had Afriyie received the instruction he sought.
- Additional criminal mental-state requirement○ not reached · basis not recorded Not counted: rule-announced/merits
fact · supports On February 16, Apollo publicly announced its planned acquisition of ADT. ADT's stock price rose by 47.5%, and the value of Afriyie's investment in ADT call options increased by 6,000% in one day. Over the course of the following week, Afriyie sold his options for a total profit of $1,564,071.60. In late February and March 2016, he wired a portion of the proceeds out of his brokerage account and into a separate savings account.
rule If the government proves beyond a reasonable doubt ... that the defendant engaged in an insider trading scheme, it must then prove that the defendant engaged in that scheme knowingly, willfully, and with intent to defraud MSD Capital .... It is for you to determine whether the government has established beyond a reasonable doubt such knowledge and intent on the part of the defendant.
rule Because an essential element of the crime charged is intent to defraud, good faith on the part of the defendant is a complete defense to the charge of insider trading. That is, the law is not violated if the defendant held an honest belief that his acts were proper and not [in] furtherance of any unlawful scheme. A person who acts on a belief or reason honestly held that turns out to be wrong is not punishable under these statutes.
held There was therefore no error in the district court's good faith instruction.
Not addressed: elements 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Case identity unavailable — citation unavailable · United States Court of Appeals for the Tenth Circuit · 2019 (15usc78j: author: unavailable · not independently reviewed)
- Intent to deceive, manipulate, or defraud✓ satisfied · proved
fact · supports Mr. Malouf and Mr. Lamonde had a financial arrangement that resulted in payments to Mr. Malouf from bond trades that he had routed through the Raymond James branch. This arrangement gave an incentive to Mr. Malouf to route his clients' bond trades through the Raymond James branch, compromising the independence of UASNM and Mr. Malouf as investment advisers. The SEC reasonably concluded that Mr. Malouf was aware of the conflict and tried to exploit it, for UASNM's outside consultant testified that Mr. Malouf had lied and resisted disclosure of the financial arrangement with Mr. Lamonde.
fact · supports Second, the evidence allowed the SEC to reasonably find that Mr. Malouf was familiar with the contents of UASNM's Forms ADV and its website. For example, Mr. Malouf admitted that he had periodically reviewed the Forms ADV and the website. Yet for several years, Mr. Malouf took no action to correct material misstatements on the forms or the website.
fact · supports Third, the evidence suggests that Mr. Malouf dragged his feet even after being directed to disclose the conflict. This directive stemmed from the outside consultant's discovery that Mr. Malouf had been receiving installment payments from the buyer of the Raymond James branch. Upon this discovery, the consultant told Mr. Malouf and UASNM that the arrangement had created a conflict of interest that needed to be disclosed. But about nine months passed before UASNM disclosed the conflict. Mr. Malouf's contribution to that delay reasonably supports a finding of scienter.
rule Conduct is extremely reckless when the petitioner knows or must have known that the conduct created a danger of misleading investors.
held For three reasons, we reject Mr. Malouf's arguments and conclude that substantial evidence supports the SEC's finding of scienter.
- Fraudulent scheme or deceptive course of business✓ satisfied · proved
fact · supports In 2007, Raymond James became concerned about the conflict of interest between (1) Mr. Malouf's role at its branch office and (2) his role at UASNM. These concerns led Raymond James to ask Mr. Malouf to choose between the two roles. Mr. Malouf opted to remain at UASNM and sold his Raymond James branch to Mr. Maurice Lamonde for roughly $1.1 million, to be paid in installments based on the Raymond James branch's collection of securities-related fees.
fact · supports To facilitate the installment payments, Mr. Malouf routed bond trades on behalf of his UASNM clients through the Raymond James branch. This way, Mr. Lamonde would receive enough in commissions to allow him to pay what he owed Mr. Malouf.
fact · supports Mr. Malouf later acknowledged that his financial arrangement with Mr. Lamonde had created a conflict of interest that should have been disclosed. But Mr. Malouf did not disclose that arrangement to UASNM's chief compliance officer or the outside consultant. Because these individuals did not know the details of the Malouf-Lamonde arrangement, UASNM not only failed to disclose Mr. Malouf's conflict of interest but also boasted that (1) UASNM's employees were not receiving any commissions or fees from the Raymond James branch and (2) UASNM was providing impartial advice untainted by any conflicts of interest.
fact · supports While UASNM was boasting of its impartiality, Mr. Malouf was participating in deciding what UASNM would disclose. He acknowledged that he had reviewed some of the Forms ADV for what to disclose and had at least some familiarity with the contents of the website. But he took no steps to remedy UASNM's misstatements or to disclose his own conflict of interest.
rule The Court expressly held that a person could incur liability under these provisions when the conduct involves another person's false or misleading statement.
held Given these definitions, we conclude that the SEC did not err in finding a fraudulent device, scheme, or artifice to defraud.
Not addressed: elements 1, 2, 3, 4, 6, 7, 8, 9, 10, 12
Case identity unavailable — citation unavailable · United States Court of Appeals for the Ninth Circuit · 2019 (15usc78j: author: unavailable · not independently reviewed)
- Importance to a reasonable investor✓ satisfied · law
fact · supports Feng also entered into marketing agreements with regional centers. Through these agreements, he reserved a number of the limited investor "spots" in certain EB-5 projects, which he then promoted on his website and tried to fill within a set time period. If one of Feng's clients made the required capital contribution to one of these regional centers, and if the USCIS approved the investor's I-526 petition, the regional center agreed to pay Feng commissions of $ 15,000 to $ 70,000. Although hundreds of regional centers participate in the EB-5 program, Feng procured investors only for ten centers, all of which agreed to pay commissions. Feng did not disclose to his clients the commissions he received from the regional centers unless they specifically asked about them.
fact · supports Here, the record includes statements of individual investors who said that if they had known about Feng's commissions, they would have attempted to negotiate their administrative fees.
rule Generally, an omission is material "if there is 'a substantial likelihood that the disclosure of the omitted fact would have been viewed by the reasonable investor as having significantly altered the "total mix" of information made available.' "
held We thus agree with the district court that Feng's failure to disclose his conflict of interest was material.
- Intent to deceive, manipulate, or defraud✓ satisfied · law
fact · supports Feng stated that he did not want to tell clients about his commissions from the regional centers because it would be costly.
fact · supports Feng's brief similarly describes his choice not to disclose as a "business decision."
rule Although there are differences in the state of mind requirements for Rule 10b-5(b) and Section 17(a)(2), a showing of intentional or knowing conduct satisfies both.
held Finally, Feng's testimony establishes intent to deceive.
- Fraudulent scheme or deceptive course of business✓ satisfied · law
fact · supports When told by some regional centers that they could only pay commissions to overseas recruiters, Feng responded that he had referral partners in China who were finding investors. He entered into marketing agreements in which he promised to relay the commissions to those individuals. He also arranged agreements that were directly between the regional centers and the individuals. The referral partners included Feng's wife, mother, and mother-in-law. Feng described these individuals in his deposition testimony as his "nominees," whose role was to be "just a surrogate to receive the money." They did not do the work of recruiting investors-Feng did that himself. After the regional centers paid commissions to the individuals, they transferred the funds to Feng. Feng asserts that the regional centers only asked for a foreign contact to pay and did not "care" who it was.
rule But, deceptive conduct that is not "inherently unlawful" may form the basis of a scheme to defraud.
held The district court addressed the fraud against the regional centers only as a scheme to defraud, not as a material omission.
held We accordingly affirm the district court's finding that Feng engaged in securities fraud in violation of Section 17(a) and Section 10(b).
✓ satisfied · lawfact · supports Approximately 20 percent of Feng's clients asked him to seek a reduced administrative fee from the regional centers. In those instances, Feng negotiated with regional centers and facilitated contracts between those regional centers and his clients for a rebate of a portion of the administrative fee. Feng did not disclose to these clients, however, that the administrative fees helped to fund his commissions, nor that the regional centers offset the clients' administrative fee rebate with a reduction in the commissions to which he was contractually entitled. Indeed, Feng asked the regional centers not to inform the clients about either fact. Feng explained in his deposition that he wanted to create the appearance to his clients that he was advocating on their behalf with the regional center and also to "keep as much of the marketing fee as possible"-that is, his commission-and to avoid further "haggl[ing]" with clients who might ask Feng to rebate more of the commission.
held The fraudulent conduct was his scheme to make the rebate appear to come from his advocacy on behalf of the client, while concealing the relationship between the reduction and his undisclosed commission.
Not addressed: elements 1, 2, 3, 6, 7, 8, 9, 10, 12
Case identity unavailable — citation unavailable · Supreme Court of the United States · 2005 (15usc78j: author: unavailable · not independently reviewed)
- Actual economic loss in private damages action✗ not satisfied · pleaded
fact · cuts-against (6) About eight months later (in November 1998), Dura announced that the FDA would not approve Dura’s new asthmatic spray device. Id., at 110a.
fact · cuts-against (7) The next day Dura’s share price temporarily fell but almost fully recovered within one week. Id., at 156a.
fact · supports Most importantly, the complaint says the following (and nothing significantly more than the following) about economic losses attributable to the spray device misstatement: “In reliance on the integrity of the market, [the plaintiffs] . . . paid artificially inflated prices for Dura securities” and the plaintiffs suffered “damagefs]” thereby. Id., at 139a (emphasis added).
rule Normally, in cases such as this one (i. e., fraud-on-the-market cases), an inflated purchase price will not itself constitute or proximately cause the relevant economic loss.
held For reasons set forth in Part II-A, supra, however, the “artificially inflated purchase price” is not itself a relevant economic loss.
- Causal connection between fraud and economic loss✗ not satisfied · pleaded
fact · cuts-against (4) On the last day of the purchase period, February 24, 1998, Dura announced that its earnings would be lower than expected, principally due to slow drug sales. Id., at 51a.
fact · cuts-against (5) The next day Dura’s shares lost almost half their value (falling from about $39 per share to about $21). Ibid.
fact · cuts-against The complaint’s failure to claim that Dura’s share price fell significantly after the truth became known suggests that the plaintiffs considered the allegation of purchase price inflation alone sufficient.
rule To “touch upon” a loss is not to cause a loss, and it is the latter that the law requires.
held And the complaint nowhere else provides the defendants with notice of what the relevant economic loss might be or of what the causal connection might be between that loss and the misrepresentation concerning Dura’s “spray device.”
Not addressed: elements 1, 2, 3, 4, 5, 6, 7, 8, 11, 12
Case identity unavailable — citation unavailable · Supreme Court of the United States · 2008 (15usc78j: author: unavailable · not independently reviewed)
- Private investor transaction causation✗ not satisfied · pleaded
fact · supports Respondents supplied Charter with the digital cable converter (set-top) boxes that Charter furnished to its customers. Charter arranged to overpay respondents $20 for each set-top box it purchased until the end of the year, with the understanding that respondents would return the overpayment by purchasing advertising from Charter. The transactions, it is alleged, had no economic substance; but, because Charter would then record the advertising purchases as revenue and capitalize its purchase of the set top boxes, in violation of generally accepted accounting principles, the transactions would enable Charter to fool its auditor into approving a financial statement showing it met projected revenue and operating cashflow numbers. Respondents agreed to the arrangement.
fact · supports To return the additional money from the set top box sales, Scientific-Atlanta and Motorola signed contracts with Charter to purchase advertising time for a price higher than fair value. The new set-top box agreements were backdated to make it appear that they were negotiated a month before the advertising agreements. The backdating was important to convey the impression that the negotiations were unconnected, a point Arthur Andersen considered necessary for separate treatment of the transactions. Charter recorded the advertising payments to inflate revenue and operating cash-flow by approximately $17 million. The inflated number was shown on financial statements filed with the Securities and Exchange Commission (SEC) and reported to the public.
fact · cuts-against Respondents had no role in preparing or disseminating Charter’s financial statements. And their own financial statements booked the transactions as a wash, under generally accepted accounting principles. It is alleged respondents knew or were in reckless disregard of Charter’s intention to use the transactions to inflate its revenues and knew the resulting financial statements issued by Charter would be relied upon by research analysts and investors.
rule Reliance by the plaintiff upon the defendant’s deceptive acts is an essential element of the § 10(b) private cause of act
held Neither presumption applies here. Respondents had no duty to disclose; and their deceptive acts were not communicated to the public.
held In all events we conclude respondents’ deceptive acts, which were not disclosed to the investing public, are too remote to satisfy the requirement of reliance.
- Fraudulent scheme or deceptive course of business○ not reached · basis not recorded Not counted: rule-announced/merits
fact · supports So that Arthur Andersen would not discover the link between Charter’s increased payments for the boxes and the advertising purchases, the companies drafted documents to make it appear the transactions were unrelated and conducted in the ordinary course of business. Following a request from Charter, Scientific-Atlanta sent documents to Charter stating — falsely—that it had increased production costs. It raised the price for set-top boxes for the rest of 2000 by $20 per box. As for Motorola, in a written contract Charter agreed to purchase from Motorola a specific number of set-top boxes and pay liquidated damages of $20 for each unit it did not take. The contract was made with the expectation Charter would fail to purchase all the units and pay Motorola the liquidated damages.
rule If this conclusion were read to suggest there must be a specific oral or written statement before there could be liability under § 10(b) or Rule 10b-5, it would be erroneous. Conduct itself can be deceptive, as respondents concede.
Not addressed: elements 1, 2, 3, 4, 5, 6, 7, 9, 10, 12
Case identity unavailable — citation unavailable · Supreme Court of the United States · 2011 (15usc78j: author: unavailable · not independently reviewed)
- Materially false statement or misleading half-truth✗ not satisfied · pleaded
fact · supports Janus Capital Group, Inc. (JCG), is a publicly traded company that created the Janus family of mutual funds. These mutual funds are organized in a Massachusetts business trust, the Janus Investment Fund. Janus Investment Fund retained JCG’s wholly owned subsidiary, JCM, to be its investment adviser and administrator. JCG and JCM are the petitioners here.
fact · cuts-against Although JCG created Janus Investment Fund, Janus Investment Fund is a separate legal entity owned entirely by mutual fund investors.
fact · cuts-against At all times relevant to this case, all of the officers of Janus Investment Fund were also officers of JCM, but only one member of Janus Investment Fund’s board of trustees was associated with JCM.
fact · cuts-against There is no allegation that JCM in fact filed the prospectuses and falsely attributed them to Janus Investment Fund.
rule For purposes of Rule 10b-5, the maker of a statement is the person or entity with ultimate authority over the statement, including its content and whether and how to communicate it.
held But this assistance, subject to the ultimate control of Janus Investment Fund, does not mean that JCM “made” any statements in the prospectuses.
Not addressed: elements 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12
Case identity unavailable — citation unavailable · Supreme Court of the United States · 2013 (15usc78j: author: unavailable · not independently reviewed)
- Importance to a reasonable investor○ not reached · basis not recorded Not counted: rule-announced/procedural
fact · supports In its complaint, Connecticut Retirement alleges that Amgen violated § 10(b) and Rule 10b-5 through certain misrepresentations and misleading omissions regarding the safety, efficacy, and marketing of two of its flagship drugs. According to Connecticut Retirement, these misrepresentations and omissions artificially inflated the price of Amgen’s stock at the time Connecticut Retirement and numerous other securities buyers purchased- the stock. When the truth came to light, Connecticut Retirement asserts, Am-gen’s stock price declined, resulting in financial losses to those who purchased the stock at the inflated price. In its answer to Connecticut Retirement’s complaint, Amgen conceded that “[a]t all relevant times, the market for [its] securities,” which are traded on the NASDAQ stock exchange, “was an efficient market”; thus, “the market for Amgen’s securities promptly digested current information regarding Amgen from all publicly available sources and reflected such information in Amgen’s stock price.” Consolidated Amended Class Action Complaint ¶¶ 199-200 in No. CV-07-2536 (CD Cal.); Answer ¶¶199-200.
rule Because materiality is judged according to an objective standard, the materiality of Amgen’s alleged misrepresentations and omissions is a question common to all members of the class Connecticut Retirement would represent.
held While Connecticut Retirement certainly must prove materiality to prevail on the merits, we hold that such proof is not a prerequisite to class certification.
- Private investor transaction causation○ not reached · basis not recorded Not counted: rule-announced/procedural
fact · supports Amgen has conceded the efficiency of the market for the securities at issue and has not contested the public character of the allegedly fraudulent statements on which Connecticut Retirement’s complaint is based.
fact · cuts-against Amgen responded to this allegation by presenting public documents—including the committee’s meeting agenda, which was published in the Federal Register more than a month before the meeting—stating that safety concerns associated with Amgen’s drug would be discussed at the meeting.
rule If the alleged misrepresentations and omissions are ultimately found immaterial, the fraud-on-the-market presumption of classwide reliance will collapse.
held The District Court thus correctly reserved consideration of Amgen’s rebuttal evidence for summary judgment or trial.
Not addressed: elements 1, 2, 3, 5, 6, 7, 9, 10, 11, 12